Advertisement

Questions 11–20

  • Yousaf Ali
Chapter

Abstract

This chapter illustrates a variety of different scenarios of rheumatic disease in succinct question and answer format. It contains ten complex cases with potentially unusual diagnoses designed to stimulate thought and further reading in this rapidly evolving specialty.

Keywords

Assessment of rheumatic diseases Complex rheumatology cases Rare rheumatic diseases Rheumatology board exam preparation Rheumatology case studies Study guide for rheumatology 

References

  1. 1.
    Jancuska J, Spivak J, Bendo J. A review of symptomatic lumbosacral transitional vertebrae: Bertolotti’s syndrome. Int J Spine Surg. 2015;9:42.  https://doi.org/10.14444/2042.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;368:1425–33.CrossRefPubMedGoogle Scholar
  3. 3.
    Dubé B-P, Dres M, Barnes D. Diaphragm dysfunction: diagnostic approaches and management strategies. J Clin Med. 2016;5(12):113.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Dai H, Zhang H, He Y. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci Rep. 2015;5:8803.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Radice A, Trezzi B, et al. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Autoimmun Rev. 2016;15(2):146–54.CrossRefPubMedGoogle Scholar
  6. 6.
    Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008;336(7639):309–12.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Speck U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol. 2001;13:12–7.CrossRefGoogle Scholar
  8. 8.
    Rudwaleit M, van der Heijde D, Landewé R, et al. The assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25–31.CrossRefPubMedGoogle Scholar
  9. 9.
    Rudwaleit M. New approaches to diagnosis and classification of axial and peripheral spondyloarthritis. Curr Opin Rheumatol. 2010;22:375–80.CrossRefPubMedGoogle Scholar
  10. 10.
    Fuss IJ. IL-17: intestinal effector or protector? Mucosal Immunol. 2011;4:366–7.CrossRefGoogle Scholar
  11. 11.
    Hueber W, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomized, double-blind placebo-controlled trial. Gut. 2012;61(12):1693–700.  https://doi.org/10.1136/gutjnl-2011-301668.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Saita Y, Ishijima M, Kaneko K. Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications. Ther Adv Chronic Dis. 2015;6(4):185–93.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Genevay S, Atlas SJ. Lumbar spinal stenosis. Best Pract Res Clin Rheumatol. 2010;24(2):253–65.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Yousaf Ali
    • 1
  1. 1.Mount Sinai HospitalNew YorkUSA

Personalised recommendations